NCT01325168View on ClinicalTrials.gov

The Effect of Intranasal Oxytocin on Emphatic Abilities in Patients With Post Traumatic Stress Disorder (PTSD)

PHASE4CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

April 30, 2013

Conditions
Post Traumatic Stress Disorder
Interventions
DRUG

syntocinon nasal spray

nasal oxytocin - 24 IU, 3 inhalations of 4IU to each nostril (45 sec waiting between the inhalations)

DRUG

placebo nasal spray

nasal placebo - 24 IU, 3 inhalations of 4IU to each nostril (45 sec waiting between the inhalations)

Trial Locations (2)

Unknown

Rambam health care campus, Haifa

Rambam Medical Center, Haifa

All Listed Sponsors
lead

Rambam Health Care Campus

OTHER

NCT01325168 - The Effect of Intranasal Oxytocin on Emphatic Abilities in Patients With Post Traumatic Stress Disorder (PTSD) | Biotech Hunter | Biotech Hunter